Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Medicare money payment

Justice Department accuses radiologist of amassing $6.5M in improper Medicare payments

James McGuckin, MD, allegedly submitted more than 500 false claims for unnecessary vascular procedures between 2016 to 2019, the DOJ said.

Thumbnail

Radiology Partners leader suggests 4 ways to fix the ‘dysfunctional’ No Surprises Act

Richard E. Heller, MD, MBA, the company's associate CMO for health policy and communications, detailed his thoughts in a recently published editorial.

The Medtronic Micra leadless pacemaker implanted inside the heart. It is about the size of a large vitamin pill and is implanted using a catheter.

Medtronic’s next-generation leadless pacemakers gain FDA approval

The two new leadless pacemakers, the Micra AV2 and Micra VR2, feature much longer batteries than previous models. 

Thumbnail

Imaging giant RadNet earns FDA greenlight for AI-based prostate MRI software

“Quantib Prostate 3.0” offers a suite of tools to help radiologists and urologists improve the quality of their assessments.

The Nanox.ARC imaging system

Nanox shares up 63% after scoring FDA clearance for new imaging system

The Nanox.ARC utilizes novel, cold-cathode X-ray tubes and charges physicians using a “pay per scan” business model. 

cardiologist doctor physician patient black diverse hypertension

Q&A: Why the future of physician payments is looking brighter

Health Exec caught up with Claire Ernst from MGMA to learn more about the possibility of physician payments being tied to inflation in the future.

Thumbnail

Heart surgeon charged with 'professional incompetency,' harmful practices

The surgeon, who now lives in a different state, has 20 days to respond to allegations made by the Iowa Board of Medicine.

The FDFA has cleared tirzepatide (Mounjaro) from Eli Lilly for the treatment of diabetes.

Eli Lilly targets FDA approval for weight loss medication

Tirzepatide, sold under the name Mounjaro, is among a handful of drugs with big buzz for their weight loss results, and approval for obesity could be a huge revenue source for Eli Lilly in the future.